Clarithromycin versus levofloxacin-based regimens for Helicobacter pylori eradication in the Kurdistan Region of Iraq: A randomized clinical trial
Helicobacter pylori infection is a predisposing factor for gastric cancer. This prospective, randomized clinical trial aimed to compare H. pylori eradication rates associated with a clarithromycin-based regimen and levofloxacin-based regimen. H. pylori infection was confirmed by a rapid urease test...
Main Authors: | Shinah A. Mohammed, Omer Q. B. Al-lela, Nawfal R. Hussein, Ramadhan S. Hajany, Laween S. Alduhoky |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Gastroenterology Insights |
Subjects: | |
Online Access: | https://www.pagepress.org/journals/index.php/gi/article/view/8256 |
Similar Items
-
Comparison of the effect of levofloxacin-based three-drug regimen with clarithromycin-based four-drug regimen in the treatment of Helicobacter pylori infection in Birjand: Short Communication
by: Fatemeh Abasnia, et al.
Published: (2021-06-01) -
The comparison of levofloxacin- and clarithromycin-based bismuth quadruple therapy regimens in Helicobacter pylori eradication
by: Abbas Arj, et al.
Published: (2020-01-01) -
The Efficacy of Levofloxacin versus Clarithromycin in Primary Quadruple Therapy for the Eradication of Helicobacter Pylori: A Prospective Randomized Controlled Clinical Trial Study
by: Vahid Sebghatollahi, et al.
Published: (2020-06-01) -
Levofloxacin-containing versus Clarithromycin-containing Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial
by: Vahid Sebghatollahi, et al.
Published: (2018-01-01) -
Pilot study: Comparing efficacy of 14-day triple therapy Clarithromycin versus levofloxacin on eradication of Helicobacter Pylori infection in Syrian population single-center experience
by: Khaled Mohammad Cheha, et al.
Published: (2018-01-01)